ANKRD1 and cardiac hypertrophy: Although there is clinical evidence that Ankrd1 mutations are involved in the pathogenesis of hypertrophic and dilated cardiomyopathy [8]–[10], there is no consensus about whether CARP enhances or attenuates cardiac hypertrophy.